SCHEMBL148392

SCHEMBL148392

Nc1cc(Br)ccc1C(=O)O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.70
GLA P06280 1/20 0.70
ALDH1A1 P00352 4/20 0.53
HPGD P15428 1/20 0.53
HSD17B10 Q99714 1/20 0.53
MAPT P10636 6/20 0.52
TDP1 Q9NUW8 3/20 0.52
CYP3A4 P08684 2/20 0.52
POLB P06746 2/20 0.52
ALOX15 P16050 1/20 0.52
PPM1B O75688 1/20 0.50
IDO1 P14902 1/20 0.48
DGAT1 O75907 1/20 0.47
KMT2A Q03164 4/20 0.47
RXFP1 Q9HBX9 2/20 0.47
GFER P55789 1/20 0.47
PLAU P00749 1/20 0.46
MEN1 O00255 3/20 0.45
THRB P10828 2/20 0.45
USP2 O75604 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6359504 0.98 KDM4E (0.68) KDM4EGLAALDH1A1HPGDHSD17B10
Nitrogen SCHEMBL28650271 0.96 KDM4E (0.66) KDM4EGLAALDH1A1HPGDHSD17B10
SCHEMBL15824364 0.85 KDM4E (0.53) KDM4EGLAALDH1A1HPGDHSD17B10
SCHEMBL29622752 0.83 KDM4E (1.00) KDM4EGLAALDH1A1HPGDMAPT
SCHEMBL145485 0.83 KDM4E (1.00) KDM4EGLAALDH1A1HPGDMAPT
SCHEMBL159651 0.83 DGAT1 (0.62) KDM4EGLAALDH1A1HPGDMAPT
SCHEMBL3895566 0.81 KDM4E (0.49) KDM4EGLAALDH1A1HPGDHSD17B10
SCHEMBL1189192 0.81 KDM4E (0.52) KDM4EGLAALDH1A1HPGDHSD17B10
SCHEMBL13967325 0.81 KDM4E (0.52) KDM4EGLAALDH1A1HPGDMAPT
SCHEMBL16230413 0.80 KDM4E (0.52) KDM4EGLAALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 960 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118084784-A Preparation method of 5-bromoquinoline-8-carbonitrile 武汉桀升生物科技有限公司 2024-05-28 CN claimed
CN-117466759-A Preparation method of 2-amino-4-bromo-5-chlorobenzoic acid 阜新清稷升科技有限公司 2024-01-30 CN claimed
CN-113461661-B 6- (pyridin-3-yl) quinazoline-4 (3H) -ketone derivative and preparation and application thereof 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 2023-11-28 CN claimed
CN-115010671-B One-step synthesis method of 2-substituted quinazolinone 江苏大学 2023-10-10 CN claimed
CN-111499513-B Synthesis method of 2,3,4, 5-tetrabromobenzoate 上海毕得医药科技股份有限公司 2023-03-14 CN claimed
CN-115010671-A One-step synthesis method of 2-substituted quinazolinone 江苏大学 2022-09-06 CN claimed
CN-110433667-B Anti-pollution anti-scaling separation membrane and preparation method thereof 天津大学 2022-03-22 CN claimed
CN-114057917-A Post-treatment ashless dispersant and preparation method thereof 中国石油天然气股份有限公司 2022-02-18 CN claimed
CN-113461661-A 6- (pyridine-3-yl) quinazoline-4 (3H) -ketone derivative and preparation and application thereof 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 2021-10-01 CN claimed
CN-107072201-B Biofilm formation inhibitor and/or remover, and biofilm formation inhibiting method and/or removing method 星光PMC株式会社 2020-11-13 CN claimed
CN-103554007-B Novel 4, 5-substituted-7-methyl formate indole diketone derivative and application thereof in antitumor drugs TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2016-05-18 CN claimed
CN-105503744-A Diphenyl urea compound containing quinazolinone and preparation method and application of diphenyl urea compound UNIV XIAN JIAOTONG 2016-04-20 CN claimed
US-20150320042-A1 BIOACTIVE ANILINE COPOLYMERS AUCKLAND UNISERVICES LIMITED (NZ) 2015-11-12 US claimed
CN-102898369-A 3-amino-7-bromoquinoline-2-ethyl formate and preparation method thereof SHANGHAI SHUYA MEDICAL TECHNOLOGY CO LTD 2013-01-30 CN claimed
CN-101808514-A bioactive aniline copolymers AUCKLAND UNISERVICES LTD 2010-08-18 CN claimed
US-20100196306-A1 BIOACTIVE ANILINE COPOLYMERS AUCKLAND UNISERVICES LIMITED (NZ) 2010-08-05 US claimed
CN-101768265-A Modified nylon and preparation method thereof UNIV SUZHOU 2010-07-07 CN claimed
EP-2190285-A1 BIOACTIVE ANILINE COPOLYMERS AUCKLAND UNISERVICES LIMITED (NZ) 2010-06-02 EP claimed
WO-2009041837-A1 BIOACTIVE ANILINE COPOLYMERS AUCKLAND UNISERVICES LIMITED (NZ) 2009-04-02 WO claimed
US-5744638-A Process for the preparation of haloanthranilic acids RIEDEL-DE HAEN AKTIENGESELLSCHAFT (DE) 1998-04-28 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150320042-A1 BIOACTIVE ANILINE COPOLYMERS ALKBH1, L3MBTL3, AGXT KDM4E 313/4885GLA 1563/4885ALDH1A1 3862/4885
US-20100196306-A1 BIOACTIVE ANILINE COPOLYMERS H1-3, L3MBTL3, ALKBH1 KDM4E 306/4885GLA 1595/4885ALDH1A1 3627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.